BioCentury | Aug 27, 2020
Distillery Therapeutics

Antisense oligos against transcription factor DUX4 for a muscular dystrophy

...K. et al. Proc. Natl. Acad. Sci. USA; published online June 29, 2020doi:10.1073/pnas.1909649117CONTACT: Toshifumi Yokota, University of Alberta...
...Yi-Wen Chen, The George Washington University, Washington, D.C.; Children’s National Health System, Washington, D.C.email: ychen@childrensnational.org Claire Quang University of Alberta The...
BioCentury | Jun 4, 2020
Product Development

WHO restarts hydroxychloroquine testing as drug fails another COVID-19 trial

...New England Journal of Medicine , researchers from the University of Minnesota, McGill University, the University of Alberta...
...Data in a Pandemic” ). Sandi Wong, Assistant Editor HCQ, hydroxychloroquine University of Minnesota McGill University Manitoba Industrial Opportunities Program (MIOP) University of Alberta WHO NIH COVID-19 cov19sci cov19count real-world...
BioCentury | Apr 29, 2020
Emerging Company Profile

Rome: tackling repeat DNA for cancer, autoimmunity

...Partners and Partners Innovation Fund University collaborators: Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, University of Alberta...
BioCentury | Dec 5, 2019
Emerging Company Profile

VaxNewMo: bioconjugating antibacterial vaccines

...in seed funding in 2020. Feldman co-invented VaxNewMo’s technology, which the company patented, while at University of Alberta...
BioCentury | Jun 18, 2019
Distillery Therapeutics

APLN17 analog identified for abdominal aortic aneurysm

...published online June 7, 2019 doi:10.1073/pnas.1900152116 CONTACT: Gavin Y. Oudit, University of Alberta, Edmonton, Alberta email: gavin.oudit@ualberta.ca Claire Quang University of Alberta Apelin...
BioCentury | Mar 29, 2019
Targets & Mechanisms

Next-wave targets at AACR 2019 start filling the blanks in the tumor microenvironment

...Acute myelogenous leukemia (AML) Patient sample, mouse, cell line Inhibiting NMT2 could help treat AML. University of Alberta...
BioCentury | Aug 1, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: July 2018

...KIF3B or ACTB could help treat metastatic squamous cell carcinoma (SCC) of the buccal mucosa University of Alberta...
BioCentury | Jul 18, 2018
Translation in Brief

Playing chicken with metastasis

...In a June study published in Nature Communications , a University of Alberta team described an in vivo...
...to visualize millions of cells at one time and pick out promising ones.” John Lewis, University of Alberta...
...Nat. Commun. study and others identified by another screening method by Lewis’ lab at the University of Alberta...
BioCentury | Jul 18, 2018
Distillery Techniques

Assays and screens

...June 14, 2018 doi:10.1038/s41467-018-04743-2 CONTACT: John Lewis, University of Alberta, Edmonton, Alberta email: jdlewis@ualberta.ca Jaime De Leon Entos Pharmaceuticals Inc. University of Alberta Actin...
BioCentury | Jun 28, 2018
Distillery Therapeutics

Autoimmune disease

...published online June 11, 2018 doi:10.1073/pnas.1722041115 CONTACT: Christopher Power, University of Alberta, Edmonton, Alberta email: chris.power@ualberta.ca Allison Johnson University of Alberta Caspase-1...
Items per page:
1 - 10 of 98
BioCentury | Aug 27, 2020
Distillery Therapeutics

Antisense oligos against transcription factor DUX4 for a muscular dystrophy

...K. et al. Proc. Natl. Acad. Sci. USA; published online June 29, 2020doi:10.1073/pnas.1909649117CONTACT: Toshifumi Yokota, University of Alberta...
...Yi-Wen Chen, The George Washington University, Washington, D.C.; Children’s National Health System, Washington, D.C.email: ychen@childrensnational.org Claire Quang University of Alberta The...
BioCentury | Jun 4, 2020
Product Development

WHO restarts hydroxychloroquine testing as drug fails another COVID-19 trial

...New England Journal of Medicine , researchers from the University of Minnesota, McGill University, the University of Alberta...
...Data in a Pandemic” ). Sandi Wong, Assistant Editor HCQ, hydroxychloroquine University of Minnesota McGill University Manitoba Industrial Opportunities Program (MIOP) University of Alberta WHO NIH COVID-19 cov19sci cov19count real-world...
BioCentury | Apr 29, 2020
Emerging Company Profile

Rome: tackling repeat DNA for cancer, autoimmunity

...Partners and Partners Innovation Fund University collaborators: Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, University of Alberta...
BioCentury | Dec 5, 2019
Emerging Company Profile

VaxNewMo: bioconjugating antibacterial vaccines

...in seed funding in 2020. Feldman co-invented VaxNewMo’s technology, which the company patented, while at University of Alberta...
BioCentury | Jun 18, 2019
Distillery Therapeutics

APLN17 analog identified for abdominal aortic aneurysm

...published online June 7, 2019 doi:10.1073/pnas.1900152116 CONTACT: Gavin Y. Oudit, University of Alberta, Edmonton, Alberta email: gavin.oudit@ualberta.ca Claire Quang University of Alberta Apelin...
BioCentury | Mar 29, 2019
Targets & Mechanisms

Next-wave targets at AACR 2019 start filling the blanks in the tumor microenvironment

...Acute myelogenous leukemia (AML) Patient sample, mouse, cell line Inhibiting NMT2 could help treat AML. University of Alberta...
BioCentury | Aug 1, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: July 2018

...KIF3B or ACTB could help treat metastatic squamous cell carcinoma (SCC) of the buccal mucosa University of Alberta...
BioCentury | Jul 18, 2018
Translation in Brief

Playing chicken with metastasis

...In a June study published in Nature Communications , a University of Alberta team described an in vivo...
...to visualize millions of cells at one time and pick out promising ones.” John Lewis, University of Alberta...
...Nat. Commun. study and others identified by another screening method by Lewis’ lab at the University of Alberta...
BioCentury | Jul 18, 2018
Distillery Techniques

Assays and screens

...June 14, 2018 doi:10.1038/s41467-018-04743-2 CONTACT: John Lewis, University of Alberta, Edmonton, Alberta email: jdlewis@ualberta.ca Jaime De Leon Entos Pharmaceuticals Inc. University of Alberta Actin...
BioCentury | Jun 28, 2018
Distillery Therapeutics

Autoimmune disease

...published online June 11, 2018 doi:10.1073/pnas.1722041115 CONTACT: Christopher Power, University of Alberta, Edmonton, Alberta email: chris.power@ualberta.ca Allison Johnson University of Alberta Caspase-1...
Items per page:
1 - 10 of 98